MEDICAL CARE FACILITIES

Nov 12, 2026

Aveanna Healthcare Holdings has frozen plans for meaningful base-wage increases for California nurses due to uncertainty regarding the permanence of a state Medicaid rate hike. The company is directing more acquisition capital toward home health and hospice in other regions, while advocating for the California reimbursement increase to become permanent beyond June 2027 to support sustained wage increases and address staffing challenges. Aveanna's leadership expressed strong disagreement with the state's current plan to implement the funding as a supplemental payment rather than a permanent rate increase.

Nov 12, 2026

American Shared Hospital Services (AMS) reported a significant third-quarter loss of $0.09 per share, missing the consensus profit expectation and experiencing a revenue shortfall despite 6.3% year-over-year growth. While the balance sheet showed improvement with increased liquidity, operational momentum slowed considerably, particularly in direct patient services and proton beam revenue, leading to a subdued outlook from management. The company's cash build provides a defensive buffer, but bears have concerns regarding debt coverage, forbearance, and leadership changes.

Nov 12, 2026

CVRx has partnered with Vassar Brother Medical Center to enable the facility's first Barostim implant procedure, providing patients with access to a new device therapy. This collaboration is a significant operational milestone for both CVRx and the medical center, expanding treatment options for specific patient populations. CVRx has also supported similar initiatives and trials earlier this year to further deploy its Barostim technology in clinical settings.

Nov 12, 2026

Washington Attorney General Nick Brown has filed a lawsuit against DaVita Inc. and Fresenius Medical Care Holdings Inc., accusing the dialysis providers of using illegal noncompete agreements. These agreements, allegedly forced upon medical directors, prevent competition and limit care options for approximately 9,000 kidney failure patients in Washington state. The lawsuit seeks to invalidate the noncompete agreements and impose penalties on the companies for violating state law.

Nov 12, 2026

Kaplan Fox & Kilsheimer LLP has filed a class action lawsuit against The Ensign Group, Inc. (NASDAQ: ENSG) on behalf of investors who purchased securities between February 10, 2022, and June 18, 2026. The lawsuit alleges that Ensign's business model involves systematic neglect of elderly patients, fraudulent practices against Medicaid and Medicare, and falsification of records. Investors have until December 7, 2026, to move the court for an opportunity to be lead plaintiff.

Nov 12, 2026

Shares of DaVita Inc. (DVA) fell by 5.14% to $174.07 on Thursday, despite a general market downturn where the S&P 500 Index and Dow Jones Industrial Average also declined. The stock closed significantly below its 52-week high of $247.49 achieved on August 3rd.

Nov 12, 2026

Aveanna Healthcare Holdings Inc. (AVAH) reported strong third-quarter results, exceeding analyst expectations for both adjusted earnings per share and revenue. Despite this beat and increased full-year guidance, the company's shares fell 6.04% in pre-market trading, possibly due to investor disappointment that the updated guidance's midpoint aligned closely with analyst consensus rather than exceeding it significantly. The company's CEO highlighted consistent year-over-year growth across all three business segments, with net income surging and strong operating and free cash flow generation.

Nov 12, 2026

Aveanna Healthcare (NASDAQ: AVAH) reported strong third-quarter earnings, exceeding consensus estimates but falling short of the "whisper" number. The company achieved a record adjusted EBITDA quarter and raised full-year guidance, driven by accelerating profitability. However, revenue growth decelerated for the third consecutive quarter, and a significant California rate win for private duty nursing was deemed temporary, raising concerns about future growth drivers.

Nov 12, 2026

National HealthCare Corp. reported a 65% dip in profits for the third quarter of 2026, totaling $14.2 million compared to $41 million in the same period of 2025. Despite this, adjusted net income saw a 13.8% increase, attributed to strategic acquisitions of skilled nursing facilities and independent living communities. The company remains confident in its liquidity, expecting to meet short-term obligations and growth plans through cash flow, current assets, and borrowing capacity.

Nov 12, 2026

CorMedix (CRMD) reported a Q3 earnings beat, exceeding expectations for both loss per share and revenue, but faced a significant decline in its DefenCath revenue. The company is pivoting towards an acquisition-led diversification strategy with the Heron acquisition, aiming to offset the collapsing DefenCath franchise. Despite reaffirming full-year 2026 revenue guidance and raising Adjusted EBITDA guidance, the long-term outlook for DefenCath remains uncertain, and the market has reacted negatively to the withdrawal of 2027 DefenCath guidance and acquisition risks.

Nov 12, 2026

Acadia Healthcare (ACHC) stock has surged 31% over six consecutive trading days, adding $834 million to its market value, largely driven by company-specific factors rather than broader market trends. While the stock has seen significant gains, its revenue growth and operating margin are below the S&P 500 Health Care median, and it lacks positive trailing earnings, presenting a mixed fundamental picture for investors. The article suggests that while such a climb warrants attention, a diversified strategy like the Trefis High Quality Portfolio is recommended over depending solely on one company's continued performance.

Nov 12, 2026

AirSculpt Technologies is hosting its first nationwide Open House event, "The Gift of Body Confidence," on November 12, 2026. This event, available both in-person at 31 centers and virtually, will offer personalized consultations, educational sessions, and Q&A sessions with AirSculpt surgeons. It aims to inform prospective and existing patients about minimally invasive body contouring procedures and will feature special promotions and partner participation.

Nov 11, 2026

HCA Healthcare's stock rose 107.8% from September 2021 to November 2026, primarily driven by a 33% reduction in diluted share count due to buybacks, which accounted for over half of the gain. Sales growth contributed about two-fifths, while an increased price-to-earnings multiple also helped. The company's net margin, however, shrank during this period, negatively impacting the stock's performance.

Nov 11, 2026

HCA Healthcare has been recognized by Military Times as a Best for Vets Employer for the seventh consecutive year, acknowledging its efforts to support veterans, service members, and military spouses in their careers. Since 2012, HCA Healthcare has hired over 75,000 military-connected individuals and is contributing $200,000 to organizations supporting veterans and military families in honor of Veterans Day. The company also offers programs like SkillBridge and a Military Colleague Network to aid in career transition and ongoing support.

Nov 11, 2026

COMPASS Pathways Plc (Nasdaq: CMPS) announced its management will attend the Jefferies Global Healthcare Conference on November 18 and 19, 2026. The company will participate in a fireside chat on November 18 and a panel on November 19, with live audio webcasts available for both events. COMPASS Pathways is a biotechnology company focused on developing new treatment options for mental health care, with an initial focus on COMP360 psilocybin for treatment-resistant depression and PTSD.

Nov 11, 2026

Pictet Asset Management Holding SA reduced its stake in HCA Healthcare by 34.0% in the third quarter, selling 45,456 shares and retaining 88,283 shares valued at approximately $37.7 million. HCA Healthcare reported strong quarterly earnings, beating analyst estimates with $7.22 EPS and $19.85 billion in revenue. The company also declared a quarterly dividend of $0.78 per share, while analysts maintain a "Moderate Buy" consensus rating with an average price target of $480.13.

Nov 11, 2026

Analysts have assigned HCA Healthcare (NYSE:HCA) an average "Moderate Buy" rating, with a consensus 12-month price target of $480.13. The company recently surpassed earnings and revenue expectations, reporting $7.22 EPS against a $6.65 consensus and $19.85 billion in revenue. HCA also declared a quarterly dividend of $0.78 per share, translating to an annual dividend of $3.12 and a 0.6% yield.

Nov 11, 2026

Cliff Donald Blessing, EVP and Chief Development Officer of Addus HomeCare Corp (NASDAQ:ADUS), sold 2,000 shares of the company's common stock on November 6, 2026, at a weighted average price of $124.18 per share. This transaction, revealed in a Form 4 filing, leaves Blessing with 10,183 shares of common stock directly owned. The sale involved multiple transactions ranging from $124.02 to $124.34.

Nov 11, 2026

Fresenius Medical Care AG & Co. KGaA (NYSE:FMS) saw its stock price fall below its 200-day moving average after Barclays downgraded the company from an "equal weight" to an "underweight" rating. The stock currently holds a consensus "Reduce" rating from analysts with an average price target of $23.42, and the company recently missed quarterly EPS estimates but exceeded revenue forecasts. Institutional investors have actively traded FMS shares, with notable increases in holdings by Pzena Investment Management LLC and Teachers Retirement System of The State of Kentucky.

Nov 11, 2026

Ensign Group, Inc. Director Marivic Uychiat Pison disposed of 102 common stock shares on November 6, 2026, to cover tax withholding obligations related to a vesting restricted stock award. The shares, valued at $181.08 each, were part of an award granted on November 6, 2024, which vests in five equal annual installments. Following this transaction, Uychiat Pison retains direct ownership of 15,013 common stock shares.

Nov 11, 2026

WW International CEO Stephen Bye recently purchased 12,500 shares of the company's stock for a total of $137,625, increasing his direct ownership to 12,500 shares. This insider transaction occurred on Tuesday, November 10th, and was disclosed in an SEC filing. The purchase coincided with a 9.6% rise in WW shares and a strong quarterly earnings report where the company beat EPS and revenue estimates.

Nov 11, 2026

WW International Director Lisa Gavales recently purchased 5,000 shares of company stock for $55,150, increasing her direct ownership to 5,000 shares. This transaction followed a strong quarterly earnings report where WW (NASDAQ:WW) beat analyst estimates for both EPS and revenue. Despite mixed analyst ratings, the company currently holds a consensus "Hold" rating with an average target price of $25.00.

Nov 11, 2026

This article provides an in-depth analysis of The Ensign Group Inc. (NASDAQ: ENSG) stock, focusing on price dynamics and execution-aware positioning. It presents key findings, including neutral near-term readings and a mid-channel oscillation pattern, and outlines three distinct AI-generated trading strategies: Position Trading, Momentum Breakout, and Risk Hedging, complete with entry, target, and stop levels. The report also offers a multi-timeframe signal analysis, detailing support and resistance levels across near-term, mid-term, and long-term horizons.

Nov 10, 2026

U.S. News & World Report has recognized 101 independently operating affiliates of The Ensign Group, Inc. as among the 2027 Best Nursing Homes. These facilities earned a "High Performing" rating, the highest distinction, for outstanding quality in short-term rehabilitation, long-term care, or both. This prestigious designation highlights the dedication of caregivers and leaders to clinical excellence and superior resident care.

Nov 10, 2026

Shares of DaVita Inc. (DVA) fell 3.37% on Tuesday, closing at $179.28. This underperformance occurred during a generally negative trading session where the S&P 500 Index (SPX) declined by 0.38% and the Dow Jones Industrial Average (DJIA) fell by 0.30%. This marks the third consecutive day of losses for DaVita's stock.

Nov 10, 2026

Oracle has broken ground on its new global headquarters in Nashville, a $4.5 billion riverfront development expected to create 8,500 permanent jobs by 2031. The project includes significant public infrastructure investment, such as a pedestrian bridge and public park, aimed at reshaping the city's economy and connecting to its existing health care industry. Despite prior layoffs and questions about job commitments, company leadership reaffirmed its long-term investment in Nashville.

Nov 10, 2026

HCA Healthcare (NYSE: HCA) has significantly outperformed the market over the past 15 years, achieving an average annual return of 21.98%. An initial investment of $100 in HCA stock 15 years ago would now be worth $1,888.26, demonstrating the substantial impact of compounded returns over time. The company currently has a market capitalization of $105.47 billion.

Nov 10, 2026

Villere ST Denis J & Co. LLC increased its stake in Option Care Health, Inc. (NASDAQ:OPCH) by 17.0% during the third quarter, acquiring an additional 132,753 shares, bringing their total holdings to 913,012 shares valued at approximately $20.5 million. Despite this insider buying, analysts have a cautious outlook, with a consensus "Hold" rating and an average price target of $29.48. Option Care Health reported quarterly EPS of $0.49, matching estimates, and revenue of $1.49 billion, slightly exceeding forecasts with a 4.1% year-over-year growth.

Nov 10, 2026

Brookdale Senior Living has revised its financial forecasts for the fourth quarter and full year due to slower-than-expected occupancy growth in Q3. The company's CEO, Nick Stengle, stated that while Q3 adjusted EBITDA met expectations, RevPAR growth fell short, leading to new sales and marketing strategies focused on increasing internal lead generation. Despite these challenges, Brookdale aims for mid-teens annual adjusted EBITDA growth in 2027 and beyond and continues its portfolio optimization efforts.

Nov 9, 2026

Investors in The Ensign Group, Inc. (NASDAQ: ENSG) have until December 7, 2026, to seek the lead plaintiff role in a securities fraud class action lawsuit. The lawsuit alleges that Ensign's business model relies on neglecting elderly patients, gaming quality data, and defrauding Medicare and Medicaid, leading to a significant drop in its stock price after critical reports were published. Glancy Prongay Wolke & Rotter LLP is reminding investors of this deadline and offering to help those who suffered losses.

Nov 9, 2026

Vanguard and Fidelity are forecasting significantly lower annual returns for US stocks over the next one to two decades, with projections suggesting less than half the gains seen in the past decade. This cautious outlook aligns with investor Michael Burry's warning of potentially 15 to 20 years of negligible or negative inflation-adjusted returns, highlighting potential challenges for retirement planning and investment expectations. The forecasts contrast sharply with the S&P 500's performance over the last 10 years and emphasize the importance of realistic financial planning.

Nov 9, 2026

Compass Pathways Plc (Nasdaq: CMPS) has completed its New Drug Application (NDA) submission to the U.S. FDA for COMP360 psilocybin, an investigational treatment for treatment-resistant depression (TRD). The submission is supported by data from two Phase 3 trials and a Phase 2b study involving over 1,000 participants. The company aims for a commercial launch in the first half of 2027, pending FDA approval, and has established commercial capabilities to ensure broad patient access.

Nov 9, 2026

American Shared Hospital Services (AMS) has announced it will hold a conference call on November 12th, 2026, at 12:00 PM ET to discuss its third-quarter 2026 financial results. The press release detailing these results will be issued before the market opens on the same day. The company provides stereotactic radiosurgery equipment and advanced radiation therapy cancer treatment services.